The breadth of hospital-acquired pneumonia: nonventilated versus ventilated patients in Pennsylvania
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Pennsylvania patient safety advisory
- Contributor(s):
- Davis, James. Finley, Edward. Pennsylvania. Patient Safety Authority. ECRI (Organization) Institute for Safe Medication Practices.
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2012
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Cross Infection -- epidemiology Cross Infection -- prevention & control Pneumonia, Bacterial -- epidemiology Pneumonia, Bacterial -- prevention & control Pneumonia, Ventilator-Associated -- epidemiology Pneumonia, Ventilator-Associated -- prevention & control Cross Infection -- etiology Cross Infection -- microbiology Cross Infection -- mortality Dental Hygienists -- statistics & numerical data Hospital Departments Incidence Intubation, Intratracheal -- adverse effects Intubation, Intratracheal -- instrumentation Life Support Care Oral Hygiene Pneumonia, Bacterial -- etiology Pneumonia, Bacterial -- microbiology Pneumonia, Bacterial -- mortality Pneumonia, Ventilator-Associated -- etiology Pneumonia, Ventilator-Associated -- microbiology Pneumonia, Ventilator-Associated -- mortality Respiration, Artificial -- adverse effects Risk Factors Tracheostomy Ventilators, Mechanical -- adverse effects Humans Pennsylvania United States
- Genre(s):
- Technical Report
- Abstract:
- Considering the evolution of measures designed to prevent nosocomial pneumonia, it makes clinical and financial sense to focus efforts on patients who require mechanical ventilation. Patients at risk for ventilator-associated pneumonia (VAP) are easily identified because they require an endotracheal tube or tracheostomy, require life support, and are commonly admitted to specific areas of the hospital. However, Pennsylvania data reveals that mortality rates for patients with nonventilator-hospital-acquired pneumonia (NV-HAP) are comparable to mortality rates for patients with VAP. Using Pennsylvania data, Pennsylvania Patient Safety Authority analysts have also determined that NV-HAP affects more people than VAP and is as lethal as and more costly than VAP. Furthermore, NV-HAP is a safety issue that is on the rise in patients in the conventional ward, and it is likely to be underreported. Data suggests that if VAP prevention is a focus at a facility, perhaps NV-HAP prevention should also share the spotlight.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-ND license. (More information)
- Illustrations:
- Illustrations
- NLM Unique ID:
- 101591716 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101591716